Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and ...

After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be wirelessly interfered with by hackers. Medtronic thinks there’s no evidence that anyone using ...

The U.S. Food and Drug Administration has approved Medtronic's MiniMed Paradigm insulin pump, which is also a glucose monitor. The U.S. Food and Drug Administration has approved Medtronic's ...

Growth potential rests heavily on the diabetes segment, where the MiniMed 780G ... think that Medtronic is positioned to dominate. As always, there are also questions of cost (insulin pens are ...

Shares of Medtronic are benefiting from an improved ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and ...